EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Use of Biomarkers in Drug Development for Regulatory Purposes

Robert N Schuck iD, Vanitha Sekar

Clinical and Translational Science · 2025

DOI: 10.1111/cts.70377 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, 2025. Verfasst von Robert N Schuck und 1 weiteren Autor:innen. Beteiligte Einrichtung: Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver…. Hauptthemen laut MEDLINE: Biomarkers, Drug Approval, Drug Development. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Appropriately validated biomarkers are important tools that can benefit drug development and regulatory assessments. For drug development purposes, biomarker development involves identifying a drug development need and context of use (COU) for the biomarker, analytically validating assays, clinically validating the biomarker for the COU, and determining if the biomarker provides benefits over current methods. This perspective provides information on determining a biomarker's COU, fit‐for‐purpose validation, and regulatory acceptance of biomarkers for drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersDrug ApprovalDrug DevelopmentHumansReproducibility of ResultsUnited StatesUnited States Food and Drug Administration

Stichwörter der Autor:innen

biomarkersdrug developmentregulatory

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Office of Drug Evaluation Sciences, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

ORCID-Profile: Robert N Schuck

Zitieren

APA

Schuck, R. N., & Sekar, V. (2025). Use of Biomarkers in Drug Development for Regulatory Purposes. Clinical and Translational Science. https://doi.org/10.1111/cts.70377

Vancouver

Schuck RN, Sekar V. Use of Biomarkers in Drug Development for Regulatory Purposes. Clinical and Translational Science. 2025. doi:10.1111/cts.70377

BibTeX
@article{Schuck2025,
  author = {Schuck, Robert N and Sekar, Vanitha},
  title = {Use of Biomarkers in Drug Development for Regulatory Purposes},
  journal = {Clinical and Translational Science},
  year = {2025},
  doi = {10.1111/cts.70377}
}
Kostenlos starten →